{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T07:10:15Z","timestamp":1731741015222,"version":"3.28.0"},"reference-count":3,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","license":[{"start":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T00:00:00Z","timestamp":1661212800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Hepatol Commun"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1002\/hep4.2071","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T19:10:02Z","timestamp":1661281802000},"page":"3598-3598","update-policy":"http:\/\/dx.doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Comment on \u201cHeterologous adenovirus\u2010vector\/messenger RNA regimen, humoral response and liver transplant recipients\u201d"],"prefix":"10.1097","volume":"6","author":[{"given":"Pathum","family":"Sookaromdee","sequence":"first","affiliation":[{"name":"Private Academic Consultant,Bangkok,Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viroj","family":"Wiwanitkit","sequence":"additional","affiliation":[{"name":"Honorary Professor, Dr. D. Y. Patil University,Pune,India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,8,23]]},"reference":[{"journal-title":"Hepatol Commun","article-title":"Heterologous adenovirus\u2010vector\/messenger RNA regimen is associated with improved severe acute respiratory syndrome coronavirus 2 humoral response in liver transplant recipients","year":"2022","key":"hep42071-bib-0001-20241116"},{"key":"hep42071-bib-0002-20241116","article-title":"Letter to the editor: coronavirus disease 2019 (COVID\u201019), infectivity, and the incubation period","volume":"53","year":"2020","journal-title":"J Prev Med Public Health"},{"key":"hep42071-bib-0003-20241116","article-title":"Antibody response to the BNT162b2 mRNA COVID\u201019 vaccine in subjects with prior SARS\u2010CoV\u20102 infection","volume":"13","year":"2021","journal-title":"Viruses"}],"container-title":["Hepatology Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep4.2071","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep4.2071","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/hep4.2071","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T06:00:30Z","timestamp":1731736830000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/hep4.2071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,23]]},"references-count":3,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1002\/hep4.2071","relation":{},"ISSN":["2471-254X","2471-254X"],"issn-type":[{"type":"print","value":"2471-254X"},{"type":"electronic","value":"2471-254X"}],"subject":[],"published":{"date-parts":[[2022,8,23]]},"assertion":[{"value":"2022-08-01","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}